International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 615-623 , 1 February 2010

Biological in situ Dose Painting for Image-Guided Radiation Therapy Using Drug-Loaded Implantable Devices

  • Robert A. Cormack, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Srinivas Sridhar, Ph.D.

      Affiliations

    • Electronics Materials Research Institute, Northeastern University, and Department of Physics, Northeastern University, Boston, Massachusetts
    • ,
  • W. Warren Suh, M.D., M.P.H.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Anthony V. D'Amico, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • G. Mike Makrigiorgos, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests to: G. Mike Makrigiorgos, Ph.D., Division of Medical Physics and Biophysics, Department of Radiation Oncology, DFCI-BWH Hospitals, 75 Francis Street, Boston, MA 02115. Tel: (617) 525-7122; Fax: (617) 582-6037

Received 17 February 2009 ,Revised 26 April 2009 ,Accepted 4 June 2009.

References 

  1. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  2. Cormack RA, Kooy H, Tempany CM, et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2000;46:207–214
  3. Kaplan ID, Meskell P, Oldenburg NE, et al. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy. 2006;5:147–151
  4. Wurm RE, Gum F, Erbel S, et al. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol. 2006;45:881–889
  5. Gultepe E, Nagesha D, Menon L, et al. High-throughput assembly of nanoelements in nanoporous alumina templates. Appl Phys Lett. 2007;90:163119
  6. Garcia-Garcia HM, Vaina S, Tsuchida K, et al. Drug-eluting stents. Arch Cardiol Mex. 2006;76:297–319
  7. Yang C, Burt HM. Drug-eluting stents: Factors governing local pharmacokinetics. Adv Drug Deliv Rev. 2006;58:402–411
  8. Li Y, Owusu A, Lehnert S. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2004;58:519–527
  9. Doiron A, Yapp DT, Olivares M, et al. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine. Cancer Res. 1999;59:3677–3681
  10. Crank J. The Mathematics of Diffusion. 2nd edition. New York: Oxford University Press; 1979;
  11. Mak M, Fung L, Strasser JF, et al. Distribution of drugs following controlled delivery to the brain interstitium. J Neurooncol. 1995;26:91–102
  12. Fung LK, Ewend MG, Sills A, et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998;58:672–684
  13. Chen D, Song D, Wientjes MG, et al. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Clin Cancer Res. 2003;9:363–369
  14. Li KW, Dang W, Tyler BM, et al. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Clin Cancer Res. 2003;9:3441–3447
  15. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release. 2000;65:271–284
  16. Tada H, Higuchi H, Wanatabe TM, et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res. 2007;67:1138–1144
  17. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res. 2000;60:4440–4445
  18. Tishler RB, Geard CR, Hall EJ, et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 1992;52:3495–3497
  19. Raaphorst GP, Wang G, Stewart D, et al. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiat Biol. 1996;69:623–631
  20. Castro Kreder N, Van Bree C, Franken NA, et al. Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. J Radiat Res (Tokyo). 2004;45:111–118
  21. von Eckardstein KL, Patt S, Kratzel C, et al. Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases. J Neurooncol. 2005;72:209–215
  22. Vukelja SJ, Anthony SP, Arseneau JC, et al. Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Anticancer Drugs. 2007;18:283–289
  23. Jabr-Milane L, van Vlerken L, Devalapally H, et al. Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release. 2008;130:121–128
  24. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551–560
  25. Li J, Wang L, Mamon H, et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med. 2008;14:579–584
  26. Cai W, Chen K, Mohamedali KA, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048–2056
  27. Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917–921

 Conflict of interest: none.

PII: S0360-3016(09)00952-3

doi: 10.1016/j.ijrobp.2009.06.039

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 615-623 , 1 February 2010

Article Tools

* Image Usage & Resolution